Neovacs S.A. Announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was EUR 145,000 compared to EUR 834,000 a year ago. Operating loss was EUR 13.080 million compared to EUR 18.329 million a year ago. Net loss was EUR 10.780 million compared to EUR 14.838 million a year ago.